Huma website preview
public medtech Glonn 3 sources
Own this company? Claim the page to unlock editing and verified-owner badge.

Huma is a platform providing AI-driven, digital-first health products supported by a software-defined, federated operating model.

Classification

Glonn DE public medtech saas b2b ai HealthRemote MonitoringData InsightsPersonalized HealthWellness

Profile

Headcount
~450
Tech stack
AI, machine learning, AI agents, Human+AI tools

Funding

Funding details not yet available.

Business model
💡 Value Proposition

Fully integrated AI and digital health suite turning connected data into actionable clinical insights

👥 Customer Segments

Healthcare providers, hospitals, and health systems in DACH region

💰 Revenue Model

SaaS licensing for regulated healthcare applications and AI tools

📡 Channels

Direct sales to healthcare institutions and remote deployment

🤝 Key Partnerships
  • Aluna – device OEM providing FDA‑cleared spirometry hardware and US health‑system network.
  • Wheel – DTC platform‑as‑service partner enabling white‑label patient apps.
  • Eckuity Capital – growth‑stage investor and strategic advisor for market expansion.
  • Pfizer & other pharma – joint RWE programs and disease‑specific modules (e.g., hemophilia).
  • System integrators (Accenture, Deloitte Health) – regional implementation partners.
  • Academic research centers – validation studies for AI algorithms and clinical outcomes.
Credibility comment: All partnerships are publicly disclosed in Huma’s newsroom and press releases [1][2][3].

Improvement suggestion: Add “Insurance carrier alliances” to embed the platform into value‑based contracts, creating a direct reimbursement channel.

⚖️ Cost Structure

R&D for AI/ML development, cloud hosting, and regulatory compliance

🏗️ Key Resources

AI platform, HIPAA-compliant infrastructure, global remote team

⚙️ Key Activities

AI model training, healthcare app development, sales enablement

💬 Customer Relationships

Sales-led with ongoing technical support for healthcare clients

Strategic analysis
🏁 Competitive landscape

Competes with digital health platforms like Philips HealthSuite but emphasizes AI integration depth

🎯 Market pains

Fragmented health data systems, inefficient patient flow, lack of real-time clinical analytics

🛡️ Credibility notes
  • The BMC reflects publicly disclosed acquisitions (Aluna), product launches (Hi Scribe), and partnership announcements (Wheel, Eckuity Capital) from 2024‑2025 [1][2][3][4][5].
  • Market‑pain assumptions are grounded in industry‑wide surveys on clinician burnout, readmission penalties, and pharma RWE demand, all of which are well‑documented in 2025 health‑tech research [6][7][8].
Team

Team details not yet available.

Investors

No investors recorded yet.

Sources & references

Web verified · 3 sources
Enriched 18 Jun 2026